cost of glp-1 drugs without insurance A That's Hard to (G)u(LP-1) Down Why are GLP-1 medications so

A meta-analysis of GLP-1RA CVOT showed that treatment with GLP-1RA reduced the risk of developing a composite kidney outcome including new-onset MA by 21% compared to placebo (HR 0.79, 95% CI 0.73-0.87), with only ELIXA and EXSCEL not achieving significant benefit [11]

The views expressed or information supplied through this article is mere opinion and observation of the author

Regul Pept 2010

Controlling the false discovery rate: a practical and powerful approach to multiple testing

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study